Isam Sharif

Experienced Senior Study Manager in safety assessment within non-clinical research with over 19 years in project management of non-clinical in vivo rodent cardiovascular research, specializing in GLP-compliant safety pharmacology/toxicology studies (including Cardiovascular, Renal, Respiratory, Gastrointestinal and CNS), in vivo models and drug development processes. Proven track in managing complex studies for regulatory submissions, leading multidisciplinary teams, and fostering collaborations across academic and industrial sectors.

Senior Study Manager III - Labcorp Early Development Laboratory Ltd. - Huntingdon, UK

(2019-06)

Study Manager II - Legacy Envigo CRS Limited - Huntingdon, UK

(2007-06 - 2019-05)

Leading preclinical safety pharmacology studies with a focus on cardiovascular respiratory, CNS, renal, GI, and reproductive (Hershberger and Uterotrophic) systems.

• Manage and oversee GLP studies, ensuring compliance with OECD and ICH Guidelines.
• Design and manage in vivo and in vitro experiments for drug safety assessments and R&D (cardiovascular, renal, metabolic and CNS).
• Ensure Adherence to SOPs, GLP, and regulatory standards.
• Coordinate resources, timelines, and budgets for multiple research projects.
• Collaborate with cross-functional teams and external partners to facilitate study execution and data interpretation.
• Ensure accurate and timely delivery of regulatory documentation and reporting.
• Supervise staff, train junior scientists, and maintain high, quality research standards.

Post-doctoral Research fellow - Cardiovascular Pharmacology - Queens Medical Research Institute, University of Edinburgh (1999-02 - 2007-01)

PhD - Physiology and Pharmacology - University of Strathclyde (1995 - 1999)

MSc - Pharmacology - University of Strathclyde (1994 - 1995)

B. Pharmacy - Pharmacy - University of Tripoli (1988 - 1993)